...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Reply from Sarah

Toniv,

Sarah has always been very prompt and respectful in her posts. It is unlikely her call to decide what info can be released. Thanks for the excellent information in your recent posts.

PVLee,

This arrangement is not as clear to some of us as you portray. Trying to understand it may be driving us insane, but just because posters, including myself, have unanswered questions about certain aspects of this arrangement doesn't mean we haven't read your posts. No need for name calling. Just agree to disagree.

Kelsee,

Yes, Sarah's promptness is good service, but do you really think it cleared anything up?

BearDownAZ

Share
New Message
Please login to post a reply